Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis

Meurer, M. and Fartasch, M. and Albrecht, G. and Vogt, Thomas and Worm, M. and Ruzicka, T. and Altmeyer, P. J. and Schneider, D. and Weidinger, G. and Braeutigam, M. (2004) Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. DERMATOLOGY, 208 (4). pp. 365-372. ISSN 1018-8665

Full text not available from this repository. (Request a copy)

Abstract

Background: Pimecrolimus cream 1% is a non-steroid, selective inflammatory cytokine inhibitor indicated for atopic dermatitis (AD). Objective: To compare the safety and efficacy of pimecrolimus cream 1%-based treatment versus conventional therapy in adults with moderate AD. Methods: Patients were randomized to receive pimecrolimus cream 1% (n = 62) or vehicle (n = 68) at the first signs/symptoms of AD, for 24 weeks as required. A moderately potent topical corticosteroid (prednicarbate 0.25% cream) was allowed in both groups to treat flares. Results: Corticosteroids were required on fewer days in the pimecrolimus group, compared with the vehicle group (9.7 vs. 37.8%, p < 0.001). Furthermore, 59.7% of pimecrolimus-treated patients experienced no flares during the study period, compared with 22.1% of vehicle-treated patients (p < 0.001). Pimecrolimus cream 1% was well tolerated throughout the study. Conclusion: For adults with moderate AD, pimecrolimus cream 1% is well tolerated, reduces the incidence of flares, reduces/eliminates corticosteroid use, improves long-term disease control and enhances the patients' quality of life. Copyright (C) 2004 S. Karger AG, Basel.

Item Type: Article
Uncontrolled Keywords: SDZ ASM 981; ANTIINFLAMMATORY DRUG; SKIN DISEASES; MAST-CELLS; MANAGEMENT; ECZEMA; PHARMACOLOGY; CHILDREN; INFANTS; RELEASE; pimecrolimus cream 1%; Elidel (R); atopic dermatitis; moderate disease; eczema; long term management; topical corticosteroids
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 02 Aug 2021 11:26
Last Modified: 02 Aug 2021 11:26
URI: https://pred.uni-regensburg.de/id/eprint/38148

Actions (login required)

View Item View Item